|
1
|
Lah TT, Novak M and Breznik B: Brain
malignancies: Glioblastoma and brain metastases. Semin Cancer Biol.
60:262–273. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berger TR, Wen PY, Lang-Orsini M and
Chukwueke UN: World Health Organization 2021 classification of
central nervous system tumors and implications for therapy for
adult-type gliomas: A review. JAMA Oncol. 8:1493–1501. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martínez-Carrillo M, Tovar-Martín I,
Zurita-Herrera M, Del Moral-Ávila R, Guerrero-Tejada R, Saura-Rojas
E, Osorio-Ceballos JL, Arrebola-Moreno JP and Expósito-Hernández J:
Salvage radiosurgery for selected patients with recurrent malignant
gliomas. Biomed Res Int. 2014:6579532014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kirkpatrick JP and Sampson JH: Recurrent
malignant gliomas. Semin Radiat Oncol. 24:289–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wick W, Gorlia T, Bendszus M, Taphoorn M,
Sahm F, Harting I, Brandes AA, Taal W, Domont J, Idbaih A, et al:
Lomustine and bevacizumab in progressive glioblastoma. N Engl J
Med. 377:1954–1963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nayak L, Molinaro AM, Peters K, Clarke JL,
Jordan JT, de Groot J, Nghiemphu L, Kaley T, Colman H, McCluskey C,
et al: Randomized phase II and biomarker study of pembrolizumab
plus bevacizumab versus pembrolizumab alone for patients with
recurrent glioblastoma. Clin Cancer Res. 27:1048–1057. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Møller S, Munck Af Rosenschöld P, Costa J,
Law I, Poulsen HS, Engelholm SA and Engelholm S: Toxicity and
efficacy of re-irradiation of high-grade glioma in a phase I dose-
and volume escalation trial. Radiother Oncol. 125:223–227. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hatiboglu MA, Akdur K, Sakarcan A,
Seyithanoglu MH, Turk HM, Sinclair G and Oztanir MN: Promising
outcome of patients with recurrent glioblastoma after Gamma
Knife-based hypofractionated radiotherapy. Neurochirurgie.
70:1015322024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guan Y, Xiong J, Pan M, Shi W, Li J, Zhu
H, Gong X, Li C, Mei G, Liu X, et al: Safety and efficacy of
hypofractionated stereotactic radiosurgery for high-grade gliomas
at first recurrence: A single-center experience. BMC Cancer.
21:1232021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wujanto C, Vellayappan B, Chang EL, Chao
ST, Sahgal A and Lo SS: Radiotherapy to the brain: What are the
consequences of this age-old treatment? Ann Palliat Med.
10:936–952. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Wang E, Pan L, Dai J, Zhang N,
Wang X, Liu X, Mei G and Sheng X: A new strategy of CyberKnife
treatment system based radiosurgery followed by early use of
adjuvant bevacizumab treatment for brain metastasis with extensive
cerebral edema. J Neurooncol. 119:369–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tatter SB: Recurrent malignant glioma in
adults. Curr Treat Options Oncol. 3:509–524. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohguri T, Imada H, Kohshi K, Kakeda S,
Ohnari N, Morioka T, Nakano K, Konda N and Korogi Y: Effect of
prophylactic hyperbaric oxygen treatment for radiation-induced
brain injury after stereotactic radiosurgery of brain metastases.
Int J Radiat Oncol Biol Phys. 67:248–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kohshi K, Kinoshita Y, Terashima H, Konda
N, Yokota A and Soejima T: Radiotherapy after hyperbaric
oxygenation for malignant gliomas: A pilot study. J Cancer Res Clin
Oncol. 122:676–678. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sen S and Sen S: Therapeutic effects of
hyperbaric oxygen: Integrated review. Med Gas Res. 11:30–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xue T, Ding JS, Li B, Cao DM and Chen G: A
narrative review of adjuvant therapy for glioma: Hyperbaric oxygen
therapy. Med Gas Res. 11:155–157. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stadlbauer A, Oberndorfer S, Zimmermann M,
Renner B, Buchfelder M, Heinz G, Doerfler A, Kleindienst A and
Roessler K: Physiologic MR imaging of the tumor microenvironment
revealed switching of metabolic phenotype upon recurrence of
glioblastoma in humans. J Cereb Blood Flow Metab. 40:528–538. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dagıstan Y, Karaca I, Bozkurt ER, Ozar E,
Yagmurlu K, Toklu A and Bilir A: Combination hyperbaric oxygen and
temozolomide therapy in C6 rat glioma model. Acta Cir Bras.
27:383–387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stuhr LEB, Raa A, Oyan AM, Kalland KH,
Sakariassen PO, Petersen K, Bjerkvig R and Reed RK: Hyperoxia
retards growth and induces apoptosis, changes in vascular density
and gene expression in transplanted gliomas in nude rats. J
Neurooncol. 85:191–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chi A, Norden AD and Wen PY: Inhibition of
angiogenesis and invasion in malignant gliomas. Expert Rev
Anticancer Ther. 7:1537–1560. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tate MC and Aghi MK: Biology of
angiogenesis and invasion in glioma. Neurotherapeutics. 6:447–457.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tyler JL, Diksic M, Villemure JG, Evans
AC, Meyer E, Yamamoto YL and Feindel W: Metabolic and hemodynamic
evaluation of gliomas using positron emission tomography. J Nucl
Med. 28:1123–1133. 1987.PubMed/NCBI
|
|
24
|
Jamieson D and Vandenbrenk HA: Measurement
of oxygen tensions in cerebral tissues of rats exposed to high
pressures of oxygen. J Appl Physiol. 18:869–876. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smoron GL: Radiobiology for the
radiologist. Am J Roentgenol. 178:600. 2002. View Article : Google Scholar
|
|
26
|
Bennett MH, Feldmeier J, Smee R and
Milross C: Hyperbaric oxygenation for tumour sensitisation to
radiotherapy. Cochrane Database Syst Rev. 4:CD0050072018.PubMed/NCBI
|
|
27
|
Al-Waili NS, Butler GJ, Beale J, Hamilton
RW, Lee BY and Lucas P: Hyperbaric oxygen and malignancies: A
potential role in radiotherapy, chemotherapy, tumor surgery and
phototherapy. Med Sci Monit. 11:RA279–RA289. 2005.PubMed/NCBI
|
|
28
|
Hadanny A and Efrati S: The
hyperoxic-hypoxic paradox. Biomolecules. 10:9582020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Adamcio B, Sperling S, Hagemeyer N,
Walkinshaw G and Ehrenreich H: Hypoxia inducible factor
stabilization leads to lasting improvement of hippocampal memory in
healthy mice. Behav Brain Res. 208:80–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Wei H, Zhou X, Zhang F and Wang C:
Hyperbaric oxygen promotes neural stem cell proliferation by
activating vascular endothelial growth factor/extracellular
signal-regulated kinase signaling after traumatic brain injury.
Neuroreport. 28:1232–1238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chaillou T and Lanner JT: Regulation of
myogenesis and skeletal muscle regeneration: Effects of oxygen
levels on satellite cell activity. FASEB J. 30:3929–3941. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Horie M, Enomoto M, Shimoda M, Okawa A,
Miyakawa S and Yagishita K: Enhancement of satellite cell
differentiation and functional recovery in injured skeletal muscle
by hyperbaric oxygen treatment. J Appl Physiol (1985). 116:149–155.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suzuki J: Endurance performance is
enhanced by intermittent hyperbaric exposure via up-regulation of
proteins involved in mitochondrial biogenesis in mice. Physiol Rep.
5:e133492017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Staples J and Clement D: Hyperbaric oxygen
chambers and the treatment of sports injuries. Sports Med.
22:219–227. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Staples JR, Clement DB, Taunton JE and
McKenzie DC: Effects of hyperbaric oxygen on a human model of
injury. Am J Sports Med. 27:600–605. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Webster AL, Syrotuik DG, Bell GJ, Jones RL
and Hanstock CC: Effects of hyperbaric oxygen on recovery from
exercise-induced muscle damage in humans. Clin J Sport Med.
12:139–150. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Harrison BC, Robinson D, Davison BJ, Foley
B, Seda E and Byrnes WC: Treatment of exercise-induced muscle
injury via hyperbaric oxygen therapy. Med Sci Sports Exerc.
33:36–42. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mekjavic IB, Exner JA, Tesch PA and Eiken
O: Hyperbaric oxygen therapy does not affect recovery from delayed
onset muscle soreness. Med Sci Sports Exerc. 32:558–563. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Babul S, Rhodes EC, Taunton JE and
Lepawsky M: Effects of intermittent exposure to hyperbaric oxygen
for the treatment of an acute soft tissue injury. Clin J Sport Med.
13:138–147. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arpa D, Parisi E, Ghigi G, Cortesi A,
Longobardi P, Cenni P, Pieri M, Tontini L, Neri E, Micheletti S, et
al: Role of hyperbaric oxygenation plus hypofractionated
stereotactic radiotherapy in recurrent high-grade glioma. Front
Oncol. 11:6434692021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aghajan Y, Grover I, Gorsi H, Tumblin M
and Crawford JR: Use of hyperbaric oxygen therapy in pediatric
neuro-oncology: A single institutional experience. J Neurooncol.
141:151–158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ogawa K, Ishiuchi S, Inoue O, Yoshii Y,
Saito A, Watanabe T, Iraha S, Toita T, Kakinohana Y, Ariga T, et
al: Phase II trial of radiotherapy after hyperbaric oxygenation
with multiagent chemotherapy (procarbazine, nimustine, and
vincristine) for high-grade gliomas: Long-term results. Int J
Radiat Oncol Biol Phys. 82:732–738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yahara K, Ohguri T, Udono H, Yamamoto J,
Tomura K, Onoda T, Imada H, Nishizawa S and Korogi Y: Radiotherapy
using IMRT boosts after hyperbaric oxygen therapy with chemotherapy
for glioblastoma. J Radiat Res. 58:351–356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gill AL and Bell CNA: Hyperbaric oxygen:
Its uses, mechanisms of action and outcomes. QJM. 97:385–395. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Valadão J, Pearl J, Verma S, Helms A and
Whelan H: Hyperbaric oxygen treatment for post-radiation central
nervous system injury: A retrospective case series. Undersea Hyperb
Med. 41:87–96. 2014.PubMed/NCBI
|
|
46
|
Kohshi K, Imada H, Nomoto S, Yamaguchi R,
Abe H and Yamamoto H: Successful treatment of radiation-induced
brain necrosis by hyperbaric oxygen therapy. J Neurol Sci.
209:115–117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vera-Rosas A, Aguiar D, Domínguez A,
Cabrera-Vicente A, Martín-Barrientos P, Cabrera R, Salas-Salas BG,
Ferrera-Alayón L, Ribeiro I, Chicas-Sett R, et al: Prospective
pilot study of quality of life in patients with severe
late-radiation-toxicity treated by low hyperbaric-oxigen-therapy.
Clin Transl Radiat Oncol. 40:1006202023.PubMed/NCBI
|
|
48
|
Jokinen-Gordon H, Barry RC, Watson B and
Covington DS: A retrospective analysis of adverse events in
hyperbaric oxygen therapy (2012–2015): Lessons learned from 1.5
million treatments. Adv Skin Wound Care. 30:125–129. 2017.
View Article : Google Scholar : PubMed/NCBI
|
